NCT02435940
- Conditions
- Abetalipoproteinemia, Abnormalities, Multiple, Achromatopsia, +100 more
- Locations
-
- Foundation Fighting Blindness Columbia, Maryland, United States
Clinical trial condition
Achromatopsia
Explore clinical trials studying Achromatopsia. Study availability and eligibility vary by location and protocol.
10 public trials
2 recruiting studies
Achromatopsia trial results
NCT07085533
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +17 more
- Locations
-
- Renmin Hospital of Wuhan University Wuhan, China
Completed
Natural History Study for Achromatopsia
NCT04124185
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- Moorfields Eye Hospital NHS Foundation Trust London, United Kingdom
Completed
Gene Therapy for Achromatopsia (CNGB3)
NCT03001310
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- University of Michigan Kellog Eye Centre Ann Arbor, Michigan, United States
- Moorfields Eye Hospital NHS Foundation Trust London, United Kingdom
Completed
Gene Therapy for Achromatopsia (CNGA3)
NCT03758404
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- Kellogg Eye Center Ann Arbor, Michigan, United States
- Moorfields Eye Hospital NHS Foundation Trust London, United Kingdom
NCT01846052
- Conditions
- Achromatopsia, Achromatopsia 3, Color Vision Defects, +9 more
- Locations
-
- VitreoRetinal Associates Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Imp Chicago, Illinois, United States
- Casey Eye Institute, Oregon Health & Science University Portland, Oregon, United States
Completed
CNTF Implants for CNGB3 Achromatopsia
NCT01648452
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +9 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Active, Not Recruiting
Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia
NCT02610582
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- University Hospital Tuebingen, Center for Ophthalmology Tübingen, Germany
Active, Not Recruiting
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)
NCT02599922
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- VitreoRetinal Associates Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Imp Chicago, Illinois, United States
- Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
Active, Not Recruiting
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
NCT02935517
- Conditions
- Achromatopsia, Color Vision Defects, Cone Dystrophy, +8 more
- Locations
-
- VitreoRetinal Associates Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
- Cincinnati Eye Institute Cincinnati, Ohio, United States